| http://www.w3.org/ns/prov#value | - In prophylactic applications, compositions containing the salts described herein are administered to a patient susceptible to or otherwise at risk of a particular disease, disorder or condition mediated, modulated or involving the PPARs, including but not limited to metabolic diseases, conditions, or disorders, as described above.
|
